A novel deletion creating a new terminal exon of the dihydrolipoyl transacylase gene is a founder mutation of Filipino maple syrup urine disease
Authors:
- Masafumi MatsuoMMMasafumi Matsuo
- 1 February 2004
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 81 (2) , 100-104
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Diagnosis and Treatment of Maple Syrup Disease: A Study of 36 PatientsPediatrics, 2002
- Maple Syrup Urine Disease: Identification and Carrier-Frequency Determination of a Novel Founder Mutation in the Ashkenazi Jewish PopulationThe American Journal of Human Genetics, 2001
- Gene Preference in Maple Syrup Urine DiseaseThe American Journal of Human Genetics, 2001
- Human mutations affecting branched chain a-ketoacid dehydrogenaseFrontiers in Bioscience-Landmark, 1998
- E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.Journal of Clinical Investigation, 1997
- Heterogeneity of mutations in Maple Syrup Urine Disease (MSUD): screening and identification of affected E1α and E1β subunits of the branched-chain α-keto-acid dehydrogenase multienzyme complexBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe.Journal of Clinical Investigation, 1991
- Identification of specific subunits of highly purified bovine liver branched-chain ketoacid dehydrogenaseBiochemistry, 1983
- Prospective Study of Maple-Syrup-Urine Disease for the First Four Days of LifeNew England Journal of Medicine, 1982
- Purification and characterization of branched chain α-keto acid dehydrogenase complex of bovine kidneyProceedings of the National Academy of Sciences, 1978